Fen Huang

Yunnan Provincial Hospital of Traditional Chinese Medicine — China

Medicine · Health Sciences

33h-index3.7kcitations288works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(115), Acute Myeloid Leukemia Research(81), Acute Lymphoblastic Leukemia research(56), Chronic Myeloid Leukemia Treatments(33), Cytomegalovirus and herpesvirus research(28)

Publications287 total

Yifei Decoction Regulates the NGF/TRKA/PI3K/AKT Signaling Axis to Inhibit the Epithelial–Mesenchymal Transformation and Proliferation of Pulmonary Epithelial Cells in Bleomycin‐Induced Pulmonary Fibrogenesis
Canadian Respiratory Journal·2026Open Access
Belumosudil for chronic graft-versus-host disease in children under 12: A retrospective analysis of effectiveness and safety
Blood·2025Open Access
Current scenario of allogeneic hematopoietic stem cell transplantation in adult patients with relapsed/refractory acute myeloid leukemia: a narrative review
Annals of Hematology·2025Open Access
Increased EBV infection and relapse following haploidentical hematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis: a propensity score matching analysis
Frontiers in Cellular and Infection Microbiology·2025· 1 citedOpen Access
Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study
BMC Medicine·2025· 3 citedOpen Access
Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation
Biomarker Research·2025Open Access
Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial
The Lancet Regional Health - Western Pacific·2025· 1 citedOpen Access
Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial
Experimental Hematology and Oncology·2025Open Access
Assessing the impacts of motorway construction on groundwater in karst mountain areas, Southwest China
Environmental Technology & Innovation·2025· 2 citedOpen Access
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial
Leukemia·2025
Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial
Journal of Translational Medicine·2025· 6 citedOpen Access
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study
British Journal of Haematology·2025· 2 cited
An Accurate Model for Microvascular Invasion Prediction in Solitary Hepatocellular Carcinoma ≤5 cm Based on CEUS and EOB-MRI: A Retrospective Study with External Validation
Academic Radiology·2025Open Access
Development of a model combining CEUS LI-RADS and clinical features for predicting glypican-3 expression in hepatocellular carcinoma
Abdominal Radiology·2025· 2 cited
An Auxiliary Decision-Making System for Radar Site Deployment
2025
Superiority of allo-SCT to auto-SCT in high-risk T-cell lymphoblastic lymphoma/leukemia patients with aaIPI ≥3: insights from a retrospective, multicenter analysis
Blood Science·2025Open Access
Exploring spatiotemporal pattern of fractional forest cover in Northeast China from 1987 to 2023: Unraveling its change-driven factors
2025Open Access
Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT
Blood Cancer Journal·2025· 3 citedOpen Access
Phillyrin regulates the JAK2/STAT3 signaling pathway by inhibiting TOP2A expression to accelerate ferroptosis in hepatocellular carcinoma
Oncology Reports·2025· 2 citedOpen Access
Haploidentical peripheral blood stem cells combined with bone marrow or unrelated cord blood as grafts for haematological malignancies: an open-label, multicentre, randomised, phase 3 trial
The Lancet Haematology·2025· 6 cited
page 1 of 15Next →

Frequent Co-authors

Qifa Liu(38), Zhiping Fan(37), Li Xuan(28), Jing Sun(28), Na Xu(21), Yu Wang(16), Ren Lin(16), Xiao‐Jun Huang(15), Hongsheng Zhou(14), Xinquan Liang(11), Min Dai(11), Pengcheng Shi(10), Yu Zhang(10), Hui Liu(10), Lan Deng(9), Danian Nie(9), Guopan Yu(9), Qianli Jiang(9), Sijian Yu(8), Jieyu Ye(8)